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Bacterial Secretion
The ability to secrete proteins is important to the pathogenesis of many bacteria. For gram-neg-
ative bacteria, the secretion system must deliver cargo through both an inner and outer mem-
brane to reach a potential target. To date, there are six known gram-negative bacterial
secretion systems, designated types I–VI secretion. For many highly pathogenic bacteria
including Yersinia pestis and Salmonella typhimurium, secretion of protein effectors directly
into target host cells is essential for virulence. Proteins secreted via the type III, IV, and VI
pathways result in direct transfer of proteins across the host membrane and into the cytosol,
and these systems will be the focus of the technology highlighted in this article.
Although the function of effector proteins secreted by these systems varies among different
pathogens, common virulence mechanisms are evident. One common function of many
secreted virulence factors is the targeting of host cytoskeletal function in order to promote
uptake or inhibit phagocytosis. Another is modulating host cell cytotoxicity by inhibiting or
promoting cell death in order to suppress innate immune function or to establish a replicative
niche. Finally, an important mechanism common to many secreted effectors is the manipula-
tion of host immune signaling. Until recently, fully evaluating the functional targets of bacterial
secretion in vivo during infection was extremely difficult.
FRET-Based β-lactamase Substrates as a Molecular Biology Tool
Förster (fluorescence) resonance energy transfer (FRET) has been used extensively as a cell
biology tool to monitor the dynamics of intermolecular interactions within cells. FRET
employs a donor fluorophore and an acceptor fluorophore in close proximity, and the emission
spectra of the donor overlaps with the absorption spectrum of the acceptor. Excitation of the
donor fluorophore results in resonance energy transfer to, and emission from, the acceptor.
Disruption of the proximity between the two fluorophores results in strong emission from the
donor upon excitation. The utility of FRET for measuring inter- and intramolecular interac-
tions has been evident for some time. Using fluorescence as a measure of proximity, fluoro-
phores exhibiting FRET can be incorporated to measure protein-folding dynamics in real time.
Further, labeling separate molecules allows for measuring protein–protein interactions, the dis-
tance between molecules, and determining protein localization within a cell.
In 1998, Zlokarnik et al. used the gene encoding a common β-lactamase along with a FRET-
based substrate to isolate individual cells with defined transcriptional responses from within a
population of mammalian cells [1]. Zlokarnik et al. designed and synthesized the membrane-
permeant ester CCF2/AM, which consists of a 7-hydroxycoumarin donor fluorophore and a
fluorescein acceptor linked by a cephalosporin antibiotic. In the intact molecule, donor excita-
tion at 405 nm (violet light) will result in fluorescein acceptor emission as green light at 520
nm that can be detected using flow cytometry or fluorescence microscopy. In the presence of
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β-lactamase, the cephalosporin linker is cleaved and the 7-hydroxycoumarin moiety is free
from FRET, resulting in emission at 447 nm (blue light). Importantly, CCF2/AM is nonpolar
and readily crosses mammalian cell membranes. Once in the cytosol of mammalian cells, the
CCF2/AM ester group is hydrolyzed, trapping CCF2 and preventing leakage out of the cell.
Thus, activation of a promoter of interest cloned upstream of the β-lactamase gene can be iden-
tified by incubating a cell population with CCF2/AM and screening for blue fluorescence.
β-lactamase Hybrids to Monitor Bacterial Secretion In Vivo
In 2004, Charpentier and Oswald demonstrated the utility of β-lactamase–protein hybrids for
analyzing bacterial secretion [2]. Briefly, a sequence encoding the common β-lactamase TEM-1
was fused to the C-terminus of known secreted effectors in enteropathogenic Escherichia coli,
and the resulting strains were used to infect HeLa cells. HeLa cells were then incubated with
CCF2/AM, and translocation of effectors was visualized using fluorescence microscopy, in
which cells that had undergone effector translocation exhibited blue fluorescence (Fig 1). In
2005, Marketon et al. extended this technique to identify cells targeted by Y. pestis type III
secretion in vivo [3]. Until this point, identifying and measuring the host cells targeted for
secretion during infection had been nearly impossible, requiring identification of a relatively
small cell population within an entire animal. The authors infected mice with Y. pestis strains
carrying translational fusions between secreted effector Yersinia outer proteins (Yops) and the
functional region of TEM-1 β-lactamase, and they were able to detect Yop translocation as blue
fluorescence during infection. To do this, Marketon et al. harvested the spleens of infected
mice and subjected splenocytes to flow cytometry using a panel of fluorescently labeled anti-
bodies to differentiate between T cells, granulocytes and neutrophils, dendritic cells, and mac-
rophages. Using this method, Marketon et al. were able to measure and quantitate Yop
translocation in vivo during infection, resulting in the discovery that Y. pestis primarily targets
cells of the innate immune system for Yop translocation. Since this initial work, this approach
has been used to examine the secretion of bacterial effector proteins for a number of bacteria
including enteropathogenic Yersinia [4,5], Salmonella [6], Pseudomonas [7], and Legionella [8]
species. Thus, the ability to monitor bacterial secretion in vivo during infection has allowed for
direct analysis of host–pathogen interactions during infection and has allowed for an unprece-
dented look at how pathogenic bacteria target the host to establish and maintain infection.
Extending Utility beyond the Identification of Target Cell Types for a
More Detailed Evaluation of Secretion
Since the initial in vivo studies, β-lactamase–protein hybrids coupled with FRET substrates
have allowed for an increasingly detailed examination of bacterial secretion. Detection tech-
niques have been refined to enable precise quantitation of secretion on a per-cell basis, allowing
for the identification of mutants affecting the rate and fidelity of effector secretion [9]. In addi-
tion, the lactam ring of CCF2/AM has been modified to create CCF4/AM, which has improved
solubility and slightly better FRET and is therefore better suited for screening applications. The
fluorescent readout of translocation coupled with mutagenesis of bacterial genes has allowed
for the detailed evaluation of translocation kinetics and mechanisms for a number of patho-
gens, as well as the identification of genes that contribute to effector secretion [10–12]. Of note,
the robust fluorescent signal associated with the commonly used FRET substrates lends itself to
the design of high throughput assays for the identification of mutants or factors that alter trans-
location in tissue culture. One potentially important application of this has involved the imple-
mentation of assays to identify inhibitors of bacterial secretion for the development of
potential therapeutics [13,14]. As the secretion of effectors is essential to the virulence of a
PLOS Pathogens | DOI:10.1371/journal.ppat.1004981 August 6, 2015 2 / 5
number of highly pathogenic gram-negative bacteria, the bacterial secretion machinery and/or
secreted effectors may prove effective as new therapeutic targets [15].
Using β-lactamase/FRET Substrates to Probe Host Elements of
Pathogenesis
An important application of FRET-substrate–effector β-lactamase hybrids has been for identi-
fying host factors that contribute to effector translocation. This has primarily been accom-
plished by examining effector translocation in the presence of inhibitors of host function or
coupled with the silencing of host genes [16,17]. For example, Newton et al. utilized small
Fig 1. Evaluating bacterial secretion using the FRET-based substrate CCF2/AM. To monitor bacterial secretion, the gene encoding a β-lactamase is
cloned in-frame with a portion of the gene encoding a predicted secreted protein to generate a translational fusion. Eukaryotic cells are infected with the
bacteria harboring the fusion protein, followed by incubation of infected cells with the fluorescent substrate CCF2/AM (or its analog CCF4/AM). CCF2/AM
consists of 7-hydroxycoumarin and fluorescein connected with a cephalosporin linker. Cells can then be examined by flow cytometry, fluorescence
microscopy, or using a plate reader in a multiwell format. Under excitation at 405 nm, the 7-hydroxycoumarin and fluorescein moieties of CCF2/AM exhibit
FRET, and emission is detected from the acceptor fluorescein as green fluorescence (520 nm). If the target cell has undergone translocation and harbors the
bacterial fusion protein, the cephalosporin linker is cleaved by β-lactamase, which disrupts FRET and results in blue fluorescence from 7-hydroxycoumarin at
447 nm.
doi:10.1371/journal.ppat.1004981.g001
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interfering RNA (siRNA) silencing to examine the role of specific host Rab GTPases in type IV
secretion of effectors for the bacterium Coxiella burnetii [16]. Similarly, Sheahan et al. com-
bined FRET of a Rho GTPase biosensor with flow cytometry in an RNA interference (RNAi)
screen to identify host factors involved in type III secretion of Yersinia pseudotuberculosis,
revealing a role for the chemokine receptor CCR5 in translocon function [18]. Coupling detec-
tion of translocation with methods to deplete specific host cell populations has contributed to
the understanding of mechanisms that govern target cell preference in vivo during infection
[5,19]. This approach was perhaps most elegantly employed by Durand et al., who used neutro-
phil depletion studies to show that the presence of professional phagocytes dictated the number
of host cells targeted for Yop translocation by the enteric pathogen Y. pseudotuberculosis [5].
A major hurdle to studying the effects of bacterial secretion in vivo is the difficulty of effi-
ciently isolating target cells from infected animals for subsequent analysis. One innovative
approach addressed this issue by utilizing the β-lactamase/FRET system to identify and isolate
host cells for further study. Using flow cytometry to sort cells from the spleens of mice infected
with Y. pseudotuberculosis, Rolán et al. identified cells that had been injected with the effector
protein YopH, a potent tyrosine phosphatase, and separated these from cells that had not been
injected [20]. These two-cell populations were collected and subsequently analyzed by western
blot to identify specific targets with decreased phosphorylation in the presence of YopH.
Expanding this analysis to evaluate host responses to effector intoxication in greater detail will
likely provide crucial information regarding the direct host–pathogen interactions that occur
during infection. Thus, the use of bacterial effector–β-lactamase hybrids along with FRET-
based substrates has proven ideal for evaluating host–microbe interactions and has allowed for
detailed evaluation of both the bacterial and host factors that contribute to a process essential
to virulence of many pathogenic bacteria. In the future, this technique will continue to be
highly useful in high-throughput approaches for studying both microbial and host cellular pro-
cesses that contribute to infection, particularly for the identification of inhibitors that might
have therapeutic applications. Further, the coupling of FRET-based substrates with fluores-
cence-activated cell sorting has great potential for the isolation and analysis of specific target
cells from infected organs, providing a high-resolution view of host–pathogen interactions dur-
ing infection.
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